Tatva Chintan Pharma Chem has scheduled its 30th Annual General Meeting for September 25, 2026. Shareholders will vote on the adoption of FY26 financials, dividend declaration, and the re-appointment of key leadership. Notably, the board is seeking approval to raise the borrowing limit to Rs 1,000 crore to support future operational and capital requirements. Shareholders should note the e-voting cut-off date of September 18, 2026, and a record date for dividend payments on September 11, 2026.
Tatva Chintan Pharma Schedules 30th AGM
Revenue for FY26 stood at Rs 4,962.96 million with a profit of Rs 390.82 million.
Reader Takeaway: Management seeks higher borrowing capacity for growth, alongside routine leadership re-appointments and dividend approval.
What just happened
Tatva Chintan Pharma Chem Ltd has officially notified shareholders of its 30th Annual General Meeting (AGM) to be held via video conferencing on September 25, 2026. The meeting will address key financial outcomes for the fiscal year ending March 31, 2026, and seek approvals for operational and governance-related resolutions.
Why this matters
The most significant proposal is the board's request to increase borrowing limits to Rs 1,000 crore under Section 180(1)(c) of the Companies Act. This move often precedes planned capital expenditure or strategic business expansion. Additionally, shareholders will vote on the re-appointment of three key executives—Managing Director Chintan Nitinkumar Shah and Whole-time Directors Ajaykumar Mansukhlal Patel and Shekhar Rasiklal Somani—for a new three-year term starting February 2027.
Key Financials for FY 2025-26
The company reported an annual revenue from operations of Rs 4,962.96 million. The annual profit for the year was recorded at Rs 390.82 million, with a total comprehensive income of Rs 392.56 million. EBITDA, including other income, reached Rs 928.58 million.
What changes now
Investors must mark their calendars for the upcoming timeline:
- Dividend Record Date: September 11, 2026.
- Book Closure Period: September 12, 2026, to September 25, 2026.
- E-voting Cut-off Date: September 18, 2026.
What to track next
The focus shifts to the specific use of the proposed Rs 1,000 crore borrowing facility. Shareholders should monitor whether the company details specific capacity expansion plans or acquisition targets in future disclosures, as the current filing cites general business operations as the primary requirement.